Skip to content
BiologicalX

Comparison

N-Acetyl Cysteine vs Semaglutide

Side-by-side of N-Acetyl Cysteine and Semaglutide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

N-Acetyl Cysteine

  • Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
  • First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
  • Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
  • Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
  • Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
  • Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route

Semaglutide

  • Long-acting GLP-1 receptor agonist with a ~7-day half-life that supports once-weekly subcutaneous dosing
  • STEP trials reported ~15 to 17% mean body-weight loss at 2.4 mg/week over 68 weeks in adults with obesity
  • Lowers HbA1c by ~1.0 to 1.8 percentage points in type 2 diabetes versus placebo
  • SELECT trial showed reduced major cardiovascular events in adults with prior CVD and overweight or obesity
  • Up to 25 to 40% of weight lost can be lean mass; pairing with resistance training and protein intake mitigates this
  • GI effects (nausea, vomiting, constipation) drive most discontinuations and ease with slow titration

Side-by-side

Attribute N-Acetyl Cysteine Semaglutide
Category supplement pharmaceutical
Also known as NAC Ozempic, Wegovy, Rybelsus
Half-life (hr) 5.6 168
Typical dose (mg) 1200 2.4
Dosing frequency 1 to 3 times daily, split dosing preferred weekly (SC); daily (oral Rybelsus)
Routes oral, iv subcutaneous, oral
Onset (hr) 1 24
Peak (hr) 2 72
Molecular weight 163.19 4113.58
Molecular formula C5H9NO3S -
Mechanism Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling. Long-acting GLP-1 receptor agonist; potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic satiety centers.
Legal status OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022) Prescription only (FDA-approved, EMA-approved)
WADA status allowed allowed
DEA / Rx OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic) Rx only (not a controlled substance); FDA-approved for type 2 diabetes (2017) and chronic weight management (2021)
Pregnancy Used clinically in pregnancy for specific indications; consult clinician Not recommended; discontinue 2 months before planned pregnancy
CAS 616-91-1 910463-68-2
PubChem CID 12035 56843331
Wikidata Q413299 Q27089394

Safety profile

N-Acetyl Cysteine

Common side effects

  • sulfur-like taste or odor
  • nausea
  • flatulence
  • diarrhea

Contraindications

  • active asthma attack (inhaled form can trigger bronchospasm)
  • known NAC hypersensitivity

Interactions

  • nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
  • activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
  • anticoagulants: theoretical additive antiplatelet effect at high doses(minor)

Semaglutide

Common side effects

  • nausea
  • vomiting
  • diarrhea
  • constipation
  • decreased appetite
  • injection-site reactions
  • fatigue

Contraindications

  • personal or family history of medullary thyroid carcinoma
  • multiple endocrine neoplasia type 2
  • pregnancy
  • history of pancreatitis (use caution)

Interactions

  • insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
  • sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
  • oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
  • warfarin: monitor INR due to altered absorption(moderate)

Which Should You Take?

N-Acetyl Cysteine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Semaglutide is the right call when one of the conditionals below applies.

Edge case: If you want to avoid prescription-only, N-Acetyl Cysteine is the more accessible choice.

Default choice: N-Acetyl Cysteine. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Semaglutide only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between N-Acetyl Cysteine and Semaglutide?

N-Acetyl Cysteine and Semaglutide differ in category (supplement vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, N-Acetyl Cysteine or Semaglutide?

N-Acetyl Cysteine half-life is 5.6 hours; Semaglutide half-life is 168 hours.

Can you stack N-Acetyl Cysteine with Semaglutide?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper